[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-CGEM":3,"homepage-market-summary":31,"stock-news-CGEM":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"CGEM","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Cullinan Therapeutics, Inc. Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed\u002Frefractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.","109","Cambridge, MA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},15.51,14.76,15.56,14.59,14.53,0.98,6.74,1149221.99638,15021,15.0575,23.19,5.71,996117.151895556,56.1,1441,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},20,[176,182,188,194,200,206,212,218,223,229,235,240,244,249,255,260,265,270,275,280],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Cullinan Therapeutics, Inc. (CGEM) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTFBlSUVsekoyREJXRENDV2NXNElEYjV3eXdhcTA3VUMySWc2QXZpOWdCNnJ3NFRRNHdiSlYtVV80aXdZYUlZb1BxVUpaQkdGTUExc2c?oc=5","Sat, 03 Oct 2026 09:55:43 GMT","Cullinan Therapeutics, Inc. (CGEM) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"$CGEM stock is down 20% today. Here's what we see in our data. - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxPOTM5eEJwMWhKTzNqNkIwMUZOZzJIaW9aSzZ5ZEZxNTJWWm5sWWFTZTBLbmY3M0dhcm4wWTlNdmRDbUEwLTE4SmJmU1RMM1R0djI4ZXFjaTZ1aVBhUkNYZDgwWkY3TVJDdTI1Y3A5RzMtTFd4N0NhS0owLXhBalVFRzhWcW1pN2ZUbEMxWmxvZk45Y3ltdElBOWRtYnpBVzdUNFE?oc=5","Wed, 23 Sep 2026 19:18:00 GMT","$CGEM stock is down 20% today. Here's what we see in our data. Quiver Quantitative","Quiver Quantitative",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"CGEM Stock Extends Losses After Cullinan Delays Arthritis Update To December — Zipalertinib Safety Worries Linger - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMihgJBVV95cUxQYTRySy1Iamh1Z0lIOXFsSEJobzlrdW85NGJQaVFvc0VXZS1Nb2pfZDhkUHZadEFTVFkzYzUxd2pGNk1oZl95LWVhN2oxVmNBUmQ5VVZTbG54YVZpN3hSb3hCVHluWFFGUzRmQjhvcUxPSTFUa2prQThTd0t2QTN1anJ4ajZMamlnM3lWc3Z5bGVRazdFcHdoRFBRdDNEdXVYc3BqbkRkOHNVUGQ3WnY1VVAxOXVZcnRfUTBsRFFaNGRjVlRTN1JzelY4azRWOVNlRkM1cEo1bXZ1b3JOYXp4em5nYWJmWk5BeEZYR2lXTmxLU2JIWi03cFNCeVlWTFJRajZQQTNB?oc=5","Thu, 24 Sep 2026 19:11:53 GMT","CGEM Stock Extends Losses After Cullinan Delays Arthritis Update To December — Zipalertinib Safety Worries Linger Stocktwits","Stocktwits",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Down 7.1% - Here's What Happened - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizgFBVV95cUxQWl9fdTlET2RiYWE1a2tWc0FvOElqM1R5N29zT2pFNEFjanY1RjFOTlRjSlQ2bTZJWWplajJqaUZ3N2ZlYVRLalNXRnhBZFBtMVBNM0ZRWUtGb0ZNcHZNVFFDa1BrMGxVVTk4eVJScFc4ZDdUdGJ0V2hkQ3JGYXRZZ3FETE9BUjhUSXBjTG95VjFscGdGZG9RUFdmTFpCZDlHcVQwY3g4c24xOENRVktXdlRVNkZhbmVlQnRqSk16NUoxeVJocVk5SXZqWm9KZw?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Down 7.1% - Here's What Happened MarketBeat","MarketBeat",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"Cullinan Therapeutics, Inc. (CGEM) stock price, news, quote and history - Yahoo Finance UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTFBTdV9Ncm1xLUNWbExvTHN4bjU1UHpvbWxIU19oaVZjR3Y1NWxlVkcyYzNJSnUwNHpvMUFqMjJfWWFSZ3NnWkFKZlhtM0NHaXBISmc?oc=5","Fri, 02 Oct 2026 06:05:53 GMT","Cullinan Therapeutics, Inc. (CGEM) stock price, news, quote and history Yahoo Finance UK","Yahoo Finance UK",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"Cullinan Therapeutics: Compelling Pullback For CLN-978's Potential In Autoimmune Diseases - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizwFBVV95cUxQc09nZ0gtWUtoOFdCZFN4emFfZFBTZVZCWE9yYThHYUdxTzNJLURyY0lVdmI3dUNZSXh6ZU5lcTBLNU1TcE5RVmtvS1RzVVkydkV4RDU3YjJkWTdmX1FxRndvM1hIc19LaHNyUUJTVS1KbnJ3eDdUTFBpQXczLTNnRVROS2tyampLQ1RBRFVFODl3TXJST0ZKVl9LOVZFYTlyMHdZWWtkNHp1VTVvVEhWUm9SVzg5eU1TTDlYZm5nbHk5QklFNWRROVIzMTNhMW8?oc=5","Tue, 29 Sep 2026 11:30:42 GMT","Cullinan Therapeutics: Compelling Pullback For CLN-978's Potential In Autoimmune Diseases Seeking Alpha","Seeking Alpha",{"title":213,"link":214,"pubDate":215,"description":216,"source":217},"Cullinan Therapeutics, Inc. - Common Stock (CGEM) Stock Price, News, Quote & History - FinancialContent","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiWkFVX3lxTE4zYmZFS0ZBOW5tWWItT0oxZlZzeU1aM2ducXJaUFFkRjZlZEVfR29HREdFWmtsdDZvYWwyUjl5dGFRdUEyOGl4TU5oS2NlWndPcjBPZ2twTW80Zw?oc=5","Mon, 28 Sep 2026 11:58:00 GMT","Cullinan Therapeutics, Inc. - Common Stock (CGEM) Stock Price, News, Quote & History FinancialContent","FinancialContent",{"title":219,"link":220,"pubDate":197,"description":221,"source":222},"Biotech Stocks Widely Dive. Here Are The Hardest Hit. - Investor's Business Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilwFBVV95cUxNS1dza3NTZzVfTGRENHNWakYxVV9lUEpSWHpIQnM5MldFYksybmNqRWhNdmR2WlFZSzN2SGQ3RzIzQWNMZ2Q1TGlEc3V5bjhiYkpvY1ZNVVFYMVUyYjliV3dfVUYtSU5iWl9YVGV6SmZBdkhYUDkyRTdYZmdSVU9Eb0lySm5aX2hfcDJfODNZUHFXYXdxZ0lZ?oc=5","Biotech Stocks Widely Dive. Here Are The Hardest Hit. Investor's Business Daily","Investor's Business Daily",{"title":224,"link":225,"pubDate":226,"description":227,"source":228},"Pipeline Data Could Shape The Case For Cullinan Therapeutics Stock - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi6wFBVV95cUxOc0pSZlJfZnBrQVhjZHZFSE9lV2dzOTRlOFZabWh5WXNDdTRvMTdhUk15T0xvSkl4a0h4bk9RRkpaT2dxVzBIamN3eHEtMzlfbnlrOS1fbnRfYWJsM0U2aWRtemN4a01iRHdhaExKZW9iVEZheW9MdDZLZkwza0RoNkQ5b18yanJyX1VZeGVPQUZVUV9GTENJQmVMV21iY0IzenBpOWN2QS1yU2xYUGt5cldGOTJ4LUNrRzEwVUJkamd1V1NhVDNlNGFkeTVXUHIxRGZORFdDWlpZMVdESmtxQjY0UTNaVzlvaWdr0gHwAUFVX3lxTE5uTjJFbzMtb293dVVPYWhtNFlBSHFCRjRXOVFGZklqRTV0VWFwa3VFcEVyRUxIMkZBd0R2ckEtaWVvRHlnOHgxak03Q00ydldoQ0N3bDVETGZSM3NLdUFjR0R0dEF3REZwZWR1d2ZCYlhVcHplTlgzVjFOb3FHX01yek93TDg2eTgtNDF5bFlMUV9EaGRlYWFYb2JRanRNUkJhYXVaNWp4TmxGaFI3elVDTXEzMzVVdXBWZXVWRmEzMzJlUC1LV1hKZG9yOHRwX0VFamt6c2s1UFdjeTBRUlliTkZSamg1UzZBN1pzYW9VUA?oc=5","Fri, 25 Sep 2026 06:48:15 GMT","Pipeline Data Could Shape The Case For Cullinan Therapeutics Stock Simply Wall Street","Simply Wall Street",{"title":230,"link":231,"pubDate":232,"description":233,"source":234},"Discipline and Rules-Based Execution in CGEM Response - news.stocktradersdaily.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizgFBVV95cUxQVkdyckNRR0hhVWhmekhpX0tNNEozWXZsOHYtUGtiV1NMT3hoYjRJOU5QaHh3OHBHZ1gwNFFPOVZ3OGtrZFNmZHBOWkU5NlBBamx0ajZ0ZmZOWUZOam5JdW1DY3U2clBGRWRBdVdBWnlVTEFOeGZ4elNSNWNPTU02R29CVE5NM0U4X0pxalowN1JMZ2RGRWQwd0t2M3Y0UnJwNXdQOXptT1ZjWnllNmZYYWJiTW1hS2FxamdTOEdMSThvT096TDUzeGRvbVNyZw?oc=5","Wed, 30 Sep 2026 18:10:02 GMT","Discipline and Rules-Based Execution in CGEM Response news.stocktradersdaily.com","news.stocktradersdaily.com",{"title":236,"link":237,"pubDate":238,"description":239,"source":199},"Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Stock Has Consensus Price Target of $33.71 According to Analysts - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi9wFBVV95cUxNREVhMlBTUk1IeW9FcUpkeXdYM1FDOGp5dmRlbUwxTnRuWkN4MjBDWkhhei1qMWRzb1h6UXlNcVd5Snp4VE9JNmZ0YzJnUGpPOTNwRmpidE9QZ2RlNjdQV1NvYVBhd3oyaHB1X1N0Q3o1QWhxOFJoMmJQVnVpSTk4cVdIbHdwUU1nRllxNjlGTVdyMjJIY3JRYnRERGNVb0lMajRZLThBT2t6anhsbEtOeTFJaUhlYmdnUzZ5T3dYeU1yZkJsRFlsdmZySFJqeG1GdWdpRlY1emwwd05TWGc0VkotRThIS2U3cHZ0Z1JkZnVrMmtqN3ZJ?oc=5","Fri, 02 Oct 2026 06:48:28 GMT","Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Stock Has Consensus Price Target of $33.71 According to Analysts MarketBeat",{"title":241,"link":242,"pubDate":197,"description":243,"source":228},"Cullinan Therapeutics (CGEM) Could Be 35% Undervalued As Phase 3 Lung Cancer Data Lands - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Cullinan Therapeutics (CGEM) Could Be 35% Undervalued As Phase 3 Lung Cancer Data Lands Simply Wall Street",{"title":245,"link":246,"pubDate":247,"description":248,"source":199},"Cullinan Therapeutics (NASDAQ:CGEM) Stock Rating Reaffirmed as \"Buy\" by BTIG Research - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxPUUc0VUMya3BaekdibUV4b3dMa3ZEbE5semdGTGUxWnUzX0RkTl9Fc2YyNjJVUHRmNTJqLXpoVHNuVTVVaTctYU1UVkJqYXJrb1N4TDlHWmRYb0RnaTlYclo3SkFuWERhdXU2aVRCVXF6RzBsRWFQTE1LeDBkd29RUElPOWZPVTEtYThuemU0aGNFREIwRHM3X2VqMk9ZZXNVdHBaTGF0NWVQbG5ucFZpRktjaWhZVTR1eUY4RVVzc1lFemU3SUE?oc=5","Tue, 29 Sep 2026 12:14:58 GMT","Cullinan Therapeutics (NASDAQ:CGEM) Stock Rating Reaffirmed as \"Buy\" by BTIG Research MarketBeat",{"title":250,"link":251,"pubDate":252,"description":253,"source":254},"Cullinan Therapeutics (CGEM) Could Be 50% Below Fair Value On Phase 3 Zipalertinib Data - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinAFBVV95cUxNbENhQUR4MDZOQlluck10UkFlWlM3T3FLV0VsczYtOVg0QkhBemZUaUg5WGxpaTZCZHV0SXNqLXZMd2t0Q2JJaE9MS20xUWtPak1wN2lzRWZTWHU1TDVVbGpMM3R6bFFiV2xzSjhjNmUzVkZUenlmdnhVLUczTFFJOXRlU1hEeFU0RkdsWDNpMENJX1E5N3ZIcHFOZTQ?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","Cullinan Therapeutics (CGEM) Could Be 50% Below Fair Value On Phase 3 Zipalertinib Data Yahoo Finance","Yahoo Finance",{"title":256,"link":257,"pubDate":258,"description":259,"source":187},"Cullinan Therapeutics Initiates FDA NDA Submission for Zipalertinib Combo in First-Line EGFR Exon 20 Insertion NSCLC Following Phase 3 REZILIENT3 Results - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilAJBVV95cUxNWF9qOTcxbWY1Q05LaE9fZm12V0Y3dFI3VmlLTWprZ2otbXE1UXJob0VwelJKaUJ6WjNhR0Q1SHBtMGFrbFFseGR1aVlWSTZ0SUw3cDJPRDRtREUtZzdnaE0wTWVhYmJoaklaVWh1RUdfVV9hYzA1YUR0ZnJkd2c2clFYeFhZcERVSmlIalFDRjg4SkQwMWx2TVNnT1pXLWFIQjhQb0c5amlEUE5EdWhKWXQydmh1NTJoN09Ib3I2YjZ6MlJ1d21LdDR3WTNoUkN6b3JHaF9iNFk1aGtjOTJMRWRRR1FVSkNMUk1tMUxhSnNxWUFPSThjcFZXMVFnMERWVy11bGpwOUZNZEc3WVNOOURmV3M?oc=5","Thu, 01 Oct 2026 23:30:00 GMT","Cullinan Therapeutics Initiates FDA NDA Submission for Zipalertinib Combo in First-Line EGFR Exon 20 Insertion NSCLC Following Phase 3 REZILIENT3 Results Quiver Quantitative",{"title":261,"link":262,"pubDate":263,"description":264,"source":254},"Cullinan Therapeutics (CGEM) Expects Three T Cell Engager Data Readouts In Q4 2026 - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiowFBVV95cUxPa193MTV0VHp6c3lqeFpCVkc0cUpyZ2dTMVFRZGFSSTAyMEt6SGVja1p6VE5YckVuYi1DVG1UVnRhQzIxbk5iN1BENzhha0FGZmdxRmV5SmlYNzF6WVhMbmdtbzNjd01LNG5aS0x0M2lZT1JBSDREQ293VEp1MjcwREpKbWRyMnhSbk5oMnZxanVhMDFiVEhRbnpyanFUZ2w4dVdJ?oc=5","Sat, 26 Sep 2026 22:07:06 GMT","Cullinan Therapeutics (CGEM) Expects Three T Cell Engager Data Readouts In Q4 2026 Yahoo Finance",{"title":266,"link":267,"pubDate":268,"description":269,"source":199},"510,325 Shares in Cullinan Therapeutics, Inc. $CGEM Purchased by Bank of America Corp DE - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi3gFBVV95cUxOM2xoRjNvMU83VTZzY3VfdC1lNC1tUVVjbk9hMmlRdmRnMHdQNTdKWUZnSlk0bHhzN1NLaS1XaUhhWGtuUGE2OW1GbTNiOWJXcHlDUEZwNTVZVDJTamR5dWJGZkVOdGMycjg4Uno4c3BwUUlrYW1WZkQ5VEsxZEJWU0ZqellzUkFaVWt3bmc3MFF5ZjZOcEdqWkdmR3lIUktUVlFybWwyZGtJX3ZfR1VYRDVtcGlTN0FFYmdjTXVTRGlVMGpuejhHblBTOW8wRWJac2NXQ2RFNkE3WWRtaEE?oc=5","Sun, 27 Sep 2026 07:10:28 GMT","510,325 Shares in Cullinan Therapeutics, Inc. $CGEM Purchased by Bank of America Corp DE MarketBeat",{"title":271,"link":272,"pubDate":273,"description":274,"source":254},"Cullinan Therapeutics Plans Q4 2026 Clinical Data Updates Across Three T Cell Engager Programs - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinAFBVV95cUxQREktdjJTcjEyLXFoWXNRd0NNbG9waDVDcE1LbTU1RktNclhnZW5pajE4a3N5NVhCaVhiYlBOYkxsV0hWejEzeW5GakNWc2NfN0lGbXpoR3gxZDlZckxNX1E3dXJFMEEyc3FyazNvNW14V29Zd0FEaGhmXzdIVG0yMHVyaHE0Q1BNYV85Nlc5OXZ4eVRUQmQyTGtscUk?oc=5","Thu, 24 Sep 2026 13:57:15 GMT","Cullinan Therapeutics Plans Q4 2026 Clinical Data Updates Across Three T Cell Engager Programs Yahoo Finance",{"title":276,"link":277,"pubDate":278,"description":279,"source":199},"Cullinan Therapeutics (NASDAQ:CGEM) Earns Buy Rating from HC Wainwright - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxQYWZfYVBSLV81VFZEaTNyQUgwaV91SXg3aTlYN19vUm52bjg2WE1UUnY1ZE9ROFNMU2NFal81OTA0YkxVS3pZcWNUNTZsekF2UnppWXp4ejl0TXRLTms5THVqaUVWcXY3ZUhXMmNuTkdVVTZNYTdmcGJHOW03Tl9zVVdIVGwxQVd5MWNaVlFlQzUzeDJQZGI4dDR2R2VDV3FqQTJSNnVFd05Odm5KYXhiQ2wtYWVmRWpQcTZUTC1Qc1hESlRzbWc?oc=5","Fri, 02 Oct 2026 12:14:50 GMT","Cullinan Therapeutics (NASDAQ:CGEM) Earns Buy Rating from HC Wainwright MarketBeat",{"title":281,"link":282,"pubDate":283,"description":284,"source":285},"CGEM Reiterated by HC Wainwright & Co. -- Price Target Maintained at $35 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxQUkV2NkFWRWNhOXpxUmJNYllFNmtaSjdaYjlXLUx6T2lBWjBSbklBcHJJR2tXeWhGempRVXlZeFNQVVpOaHZtY0NFOTRUZ2lmWjZrWkhPZTktVUY5OW9MSnpzX1ZCRTVwNy1wZjJERmZmSTBiaG9HejgwaWh3b2M2Q3VVUzlRX2lxRUw2NWF2eFNyZFJZNVBHTHdsN1ZkTWJtY3U5UUlfNA?oc=5","Fri, 02 Oct 2026 11:28:43 GMT","CGEM Reiterated by HC Wainwright & Co. -- Price Target Maintained at $35 GuruFocus","GuruFocus"]